BIIB

BIOGEN INC

Healthcare | Large Cap

$3.49

EPS Forecast

$2,322

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

$3.49

Revenue Forecast:

$2,322

EPS Surprise Forecast:

$0.440

Revenue Surprise Forecast:

$70

Post-release price volatility - Medium

Post-release Overnight Move:

±5.7%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

82%

Probability of beating revenue consensus:

80%

Probability of beating both EPS & revs consensus:

70%

Probability of missing both EPS & revs consensus:

8%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

1

Beta (β)

Forward Looking Beta (β):

1.12

Earnings volatility

EPS standard deviation:

$1.15

Revenue standard deviation:

$153

As % of share price:

0.63% EXTREME UNCERTAINTY

As % of market cap:

0.57% HIGH

Confidence intervals and percentiles

EPS 95th %ile:

$5.12

Revenue 95th %ile:

$2,547

EPS 75th %ile:

$3.92

Revenue 75th %ile:

$2,384

EPS 25th %ile:

$3.19

Revenue 25th %ile:

$2,269

EPS 5th %ile:

$2.38

Revenue 5th %ile:

$2,140

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

45% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

50% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$10

Bid-ask per Share:

$0.18